Strategy Driven

JULY 13, 2011

Pharmaceutical companies have long needed deep scientific-innovation leadership capabilities but relatively few general managers. Kaplan and Norton point out that customer satisfaction, internal business processes, learning, and revenue growth are important drivers of long-term performance. Copyright 2007-2011 by StrategyDriven, Inc.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Harvard Business Review

DECEMBER 6, 2013

That word is innovation, and it’s quickly losing whatever meaning it once had. Journal writer Dennis Berman begins by citing Kellogg CEO John Bryant, the respected head of a well-run company, who was describing one of its “innovations” for 2013. an innovation, then what isn’t an innovation?

Innovation 11

Innovation Kaplan Insurance Business Model 11

Harvard Business Review

OCTOBER 26, 2017

There’s no shortage of articles, books, and talks on the subject. Each innovation brings lessons that inform ongoing operations. They should be asked to test innovative steps they think will make a difference and to learn from the process. The projects aimed to have people experiment with innovation.

Management 8

Management Kaplan Short-term Innovation 8

First Friday Book Synopsis

FEBRUARY 1, 2012

Harvard Business Review on Aligning Technology with Strategy Various Contributors Harvard Business Review Press (2011) How and why technology should support your organization’s strategy…not the other way around This is one of the volumes in a series of anthologies of articles that first appeared in Harvard Business Review.

Review 80

Review Technology Strategy Books 80

First Friday Book Synopsis

FEBRUARY 15, 2011

Here is an article written by William C. Taylor for BNET (January 4, 2011), The CBS Interactive Business Network. To check out an abundance of valuable resources and obtain a free subscription to one or more of the BNET newsletters, please click here. * * * Ever since the publication, nearly two decades ago, of [.].

Taylorism 80

Taylorism Taylor Newsletter Resources 80

Harvard Business Review

MAY 18, 2017

Kaplan’s balanced scorecard or Clayton Christensen’s disruptive innovation. I’ll give a few examples, starting with his first HBR article but mostly concerning later work. . One of the many articles circling back to this topic of late revisited the still-common use of NPV hurdles in investment decisions.)

Management 8

Management Balanced Scorecard NPV Article 8

Harvard Business Review

OCTOBER 14, 2013

The University of Texas MD Anderson Cancer Center is seeking to reduce its cost structure by redesigning its health-care-delivery model to reflect the true costs of care (the early stages of the project were described in a 2011 Harvard Business Review article by Robert S. Kaplan and Michael E. Leading Health Care Innovation.

Health Care 8

Health Care Kaplan Porter Cost 8

Harvard Business Review

JULY 25, 2017

A company has an innovative idea, which for a while provides competitive advantage. Later on, a new innovator comes along and pushes it aside. Finance may be moving from a period without much competition into one of disruption, while technology is moving from a period of intense innovation into one of concentrated market power.

Competitive Advantage 8

Competitive Advantage Kaplan Innovation Industry 8

Harvard Business Review

JULY 13, 2018

After all, every innovation somehow recombines or reimagines things that already exist. For example, researchers Sarah Kaplan and Keyvan Vakili found that recombining ideas from one domain of specialization, as opposed to multiple domains, led to more novel innovations in the area of nanotubes.

Creativity 8

Creativity Kaplan Productivity Products 8

Harvard Business Review

OCTOBER 13, 2015

But, as Michael Porter and Robert Kaplan of Harvard Business School have argued , we need to examine costs at a more granular level at which clinical outcomes are matched with the business and administrative processes. Aggressive supply-side reforms.

Health Care 8

Health Care Insurance Price Cost 8

Harvard Business Review

JULY 18, 2016

We have also seen innovation in other dimensions of pay that are more important than ratios – for example, the lengthening of vesting horizons (to encourage the CEO to think for the long term) and paying executives with debt rather than just equity (to dissuade excessive risk-taking). What about equality?

CEO 8

CEO Golden Parachute Politics Short-term 8

Harvard Business Review

OCTOBER 22, 2015

The HBS team has been using Time-Driven Activity-Based Costing (TDABC), an approach initially proposed by one of us (Bob Kaplan) and Michael Porter, to help providers pursue the value-based delivery of care. Every Mayo value-improvement project tests one or more innovations for improving the value of care.

Mayo 8

Mayo Health Care Committee Project 8

Harvard Business Review

OCTOBER 9, 2015

“The proper goal for any health care delivery system is to improve the value delivered to patients … To properly manage value, both outcomes and cost must be measured at the patient level,” Harvard’s Robert Kaplan and Michael Porter tell us. But, why do we only define patient value by outcomes and cost?

Health Care 8

Health Care Cost Kaplan Porter 8